Entry: P46806 Genes: hom ML1129 Length: 441 aa

Homoserine dehydrogenase (HDH) (HSD)

DHOM_MYCLE • Mycobacterium leprae (strain TN)
Navigate Overview Model Scores RCSB 1D Mol* Pockets B-Cell Epitopes Function and interactions Ontology and localisation Sequence features and PTMs Evidence and cross-references

Summary

Download FASTA UniProt: P46806 ML Locus: ML1129
Entry P46806
Reviewed reviewed
Entry Name DHOM_MYCLE
Gene Names hom ML1129
ML locus tag ML1129
Organism Mycobacterium leprae (strain TN)
Length 441 aa
Mass 45606 Da
Annotation 3.0
Annotation Summary

Evidence and cross-references

PubMed ID 11234002
DOI ID 10.1038/35059006
STRING 272631.gene:17574956;
KEGG mle:ML1129;
eggNOG COG0460;
OrthoDB 9808167at2;
InterPro IPR045865;IPR002912;IPR005106;IPR016204;IPR001342;IPR019811;IPR036291;

Oligomer Models

Best Boltz2 oligomer and local AlphaFold‑3 homooligomer structure models matched to ML1129, with the same model switching, Mol*, Nightingale, pLDDT, PAE, and download functionality as monomers.
Count: 2
Assembly Method Template / Source Overall Rank Download
Homo 2-mer Boltz2 6DZS Assembly 2 0.936519 Download Model
Homo 2-mer AlphaFold‑3 6DZS Assembly 2 — Download Model

Ligands

Curated ligands imported from the selected oligomer template/YAML rows. The displayed ligand code is the original template CCD code; predicted-model placeholders such as LIG1/LIG2 are not shown. Click a ligand code to focus the ligand in Mol*.
Ligands: 0
Ligand Code Ligand Name PubChem ID
No curated ligand rows were found for this oligomer in the database.

Monomer Models

Monomer structure models for ML1129, retaining all existing model selection, Mol*, Nightingale, pLDDT, PAE, and download functionality.
Count: 4
Assembly Method Overall Rank Download
Monomer Boltz2 0.904017 Download Model
Monomer AlphaFold‑3 0.919727 Download Model
Monomer Boltz 0.909155 Download Model
Monomer CHAI 0.186605 Download Model

Sequence & Feature Viewer

Residue-level feature tracks for the loaded model — pLDDT confidence colouring, mapped annotations, and interactive PAE selection ranges. Drag a region on the heatmap to highlight it here and in Mol*.
RCSB 1D
Sequence viewer will initialise once a structure model is loaded.
Mol* — ML1129

Mol* Structure Viewer

Local mmCIF model display for ML1129 with Mol* controls hidden.
Default: Boltz2
Preparing Boltz2 model 0 for ML1129…
Residue focus: none
Heterooligomer ML IDs / chain selection

PAE Map Panel

Predicted aligned error heatmap for the currently loaded model, when pairwise confidence data are available in the local mmCIF.
PAE • Waiting for Model
PAE Heatmap
Loading pairwise confidence data for the selected model…
Scored residue
Aligned residue
Hover over the heatmap to inspect residue-pair PAE values.
Click a cell or drag across the heatmap to select residue blocks and mirror them in the sequence viewer.

B-cell Epitope Propensity

Per-residue conformational B-cell epitope predictions from DiscoTope-3.0.
Epitope · Loading
Low
Epitope
Residue number Residue type DiscoTope-3.0 score Focus
Loading epitope predictions…
Click a residue to focus it in Mol*.
Annotation Summary

Function and interactions

EC number 1.1.1.3
Pathway PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-homoserine from L-aspartate: step 3/3. {ECO:0000250|UniProtKB:P31116}.; PATHWAY: Amino-acid biosynthesis; L-threonine biosynthesis; L-threonine from L-aspartate: step 3/5. {ECO:0000250|UniProtKB:P31116}.
Catalytic activity CATALYTIC ACTIVITY: Reaction=L-homoserine + NADP(+) = L-aspartate 4-semialdehyde + NADPH + H(+); Xref=Rhea:RHEA:15761, ChEBI:CHEBI:15378, ChEBI:CHEBI:57476, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:537519; EC=1.1.1.3; Evidence={ECO:0000250|UniProtKB:P31116}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:15763; Evidence={ECO:0000250|UniProtKB:P31116}; CATALYTIC ACTIVITY: Reaction=L-homoserine + NAD(+) = L-aspartate 4-semialdehyde + NADH + H(+); Xref=Rhea:RHEA:15757, ChEBI:CHEBI:15378, ChEBI:CHEBI:57476, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:537519; EC=1.1.1.3; Evidence={ECO:0000250|UniProtKB:P31116}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:15759; Evidence={ECO:0000250|UniProtKB:P31116};
Binding site BINDING 17; /ligand="NADP(+)"; /ligand_id="ChEBI:CHEBI:58349"; /evidence="ECO:0000250|UniProtKB:F9VNG5"; BINDING 18; /ligand="NAD(+)"; /ligand_id="ChEBI:CHEBI:57540"; /evidence="ECO:0000250|UniProtKB:P31116"; BINDING 18; /ligand="NADP(+)"; /ligand_id="ChEBI:CHEBI:58349"; /evidence="ECO:0000250|UniProtKB:F9VNG5"; BINDING 18; /ligand="NADPH"; /ligand_id="ChEBI:CHEBI:57783"; /evidence="ECO:0000250|UniProtKB:O58802"; BINDING 47; /ligand="NAD(+)"; /ligand_id="ChEBI:CHEBI:57540"; /evidence="ECO:0000250|UniProtKB:P31116"; BINDING 49; /ligand="NADP(+)"; /ligand_id="ChEBI:CHEBI:58349"; /evidence="ECO:0000250|UniProtKB:F9VNG5"; BINDING 49; /ligand="NADPH"; /ligand_id="ChEBI:CHEBI:57783"; /evidence="ECO:0000250|UniProtKB:O58802"; BINDING 50; /ligand="NADP(+)"; /ligand_id="ChEBI:CHEBI:58349"; /evidence="ECO:0000250|UniProtKB:F9VNG5"; BINDING 107; /ligand="NADP(+)"; /ligand_id="ChEBI:CHEBI:58349"; /evidence="ECO:0000250|UniProtKB:F9VNG5"; BINDING 107; /ligand="NADPH"; /ligand_id="ChEBI:CHEBI:57783"; /evidence="ECO:0000250|UniProtKB:O58802"; BINDING 131; /ligand="Na(+)"; /ligand_id="ChEBI:CHEBI:29101"; /evidence="ECO:0000250|UniProtKB:P31116"; BINDING 134; /ligand="Na(+)"; /ligand_id="ChEBI:CHEBI:29101"; /evidence="ECO:0000250|UniProtKB:P31116"; BINDING 136; /ligand="Na(+)"; /ligand_id="ChEBI:CHEBI:29101"; /evidence="ECO:0000250|UniProtKB:P31116"; BINDING 138; /ligand="Na(+)"; /ligand_id="ChEBI:CHEBI:29101"; /evidence="ECO:0000250|UniProtKB:P31116"; BINDING 189; /ligand="NADP(+)"; /ligand_id="ChEBI:CHEBI:58349"; /evidence="ECO:0000250|UniProtKB:F9VNG5"; BINDING 192; /ligand="L-homoserine"; /ligand_id="ChEBI:CHEBI:57476"; /evidence="ECO:0000250|UniProtKB:P31116"; BINDING 192; /ligand="NADP(+)"; /ligand_id="ChEBI:CHEBI:58349"; /evidence="ECO:0000250|UniProtKB:F9VNG5"; BINDING 203; /ligand="L-homoserine"; /ligand_id="ChEBI:CHEBI:57476"; /evidence="ECO:0000250|UniProtKB:P31116"; BINDING 309; /ligand="NAD(+)"; /ligand_id="ChEBI:CHEBI:57540"; /evidence="ECO:0000250|UniProtKB:P31116"; BINDING 309; /ligand="NADP(+)"; /ligand_id="ChEBI:CHEBI:58349"; /evidence="ECO:0000250|UniProtKB:F9VNG5"; BINDING 309; /ligand="NADPH"; /ligand_id="ChEBI:CHEBI:57783"; /evidence="ECO:0000250|UniProtKB:O58802"
Cofactor COFACTOR: Name=a metal cation; Xref=ChEBI:CHEBI:25213; Evidence={ECO:0000250|UniProtKB:P31116}; Note=A sodium ion is seen in the structure; a metal ion may subtly affect the relative position of the nucleotide-binding region to influence enzyme activity, and could increase the stability of the enzyme. {ECO:0000250|UniProtKB:P31116};
Active site ACT_SITE 207; /note="Proton donor"; /evidence="ECO:0000255"
Annotation Summary

Ontology and localisation

Gene Ontology (biological process) methionine biosynthetic process [GO:0009086]; threonine biosynthetic process [GO:0009088]
Gene Ontology (GO) homoserine dehydrogenase activity [GO:0004412]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NADP binding [GO:0050661]; methionine biosynthetic process [GO:0009086]; threonine biosynthetic process [GO:0009088]
Gene Ontology (molecular function) homoserine dehydrogenase activity [GO:0004412]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NADP binding [GO:0050661]
Gene Ontology IDs GO:0004412; GO:0009086; GO:0009088; GO:0046872; GO:0050661; GO:0070403
Protein families Homoserine dehydrogenase family
Sequence similarities SIMILARITY: Belongs to the homoserine dehydrogenase family. {ECO:0000305}.
Annotation Summary

Sequence features and PTMs

Chain CHAIN 1..441; /note="Homoserine dehydrogenase"; /id="PRO_0000066701"
Domain [FT] DOMAIN 356..435; /note="ACT"; /evidence="ECO:0000255|PROSITE-ProRule:PRU01007"